SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-24-000137
Filing Date
2024-01-31
Accepted
2024-01-31 07:00:30
Documents
15
Period of Report
2024-01-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K a53889897.htm   iXBRL 8-K 27625
2 EXHIBIT 99.1 a53889897ex99_1.htm EX-99.1 1063387
  Complete submission text file 0001157523-24-000137.txt   1290467

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20240131.xsd EX-101.SCH 3869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20240131_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20240131_pre.xml EX-101.PRE 16047
16 EXTRACTED XBRL INSTANCE DOCUMENT a53889897_htm.xml XML 4102
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 24580609
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)